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Abstract Mutants of the heme monooxygenase cytochrome
P450cam in which Y96 had been replaced with hydrophobic
residues, have been shown to oxidise naphthalene and pyrene with
rates one to two orders of magnitude faster than the wild-type.
Naphthalene was oxidised to 1- and 2-naphthol, probably via the
1,2-oxide intermediate. In the case of the Y96F mutant,
naphthalene was oxidised at a rate comparable to camphor.
Pyrene oxidation gave 1,6- and 1,8-pyrenequinone with no
evidence for attack at the K-region, in contrast to mammalian
enzymes. The results show that the Y96 residue plays a key role
in controlling the substrate range of P450cam.
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1. Introduction
Polycyclic aromatic hydrocarbons (PAHs) are hazardous
and recalcitrant environmental contaminants [1^3] mainly de-
rived from the anthropogenic pyrolysis of organic matter such
as fossil fuel consumption and coal-re¢ning processes [4].
They are procarcinogens, being converted to highly carcino-
genic oxidation products by the heme-dependent cytochrome
P450 enzymes such as CYP1A1 [5]. P450 monooxygenases are
also utilized for the initial oxidation step in the biodegrada-
tion of PAHs [6]. The PAH oxidation activity of P450 en-
zymes is therefore of wide interest, and we report here the
oxidation of PAHs by genetically engineered forms of the
heme monooxygenase cytochrome P450cam.
Cytochrome P450cam (CYP101), which is found in the soil
bacterium Pseudomonas putida, is the most well-characterised
P450 monooxygenase [7^9]. We have investigated the protein
engineering of P450cam for the oxidation of unnatural sub-
strates [10^12]. In particular, we have shown that P450cam
can be engineered by a single active site mutation, Y96A, to
oxidise diphenylmethane which was not attacked by wild-type
P450cam but was regio-speci¢cally hydroxylated by the Y96A
mutant to para-hydroxydiphenylmethane [13]. This was attrib-
uted to both the increased hydrophobicity of the substrate
pocket and the possibility that the Y96A mutation generated
space to accommodate diphenylmethane which is signi¢cantly
larger than camphor. Since both these factors might also en-
hance the binding of PAHs, we investigated the oxidation of
naphthalene and pyrene by mutants of P450cam in which Y96
had been replaced by the residues Gly, Ala, Val, and Phe,
which have hydrophobic side chains of di¡erent sizes.
2. Materials and methods
2.1. General
Bu¡er components were from Biometra. HPLC grade acetonitrile
and chloroform, naphthalene, 1-naphthol, 2-naphthol, pyrene, and 1-
hydroxypyrene were from Aldrich. UV/Vis spectra were recorded on a
CARY 1E double-beam spectrophotometer. 1H NMR spectra were
recorded at 500 MHz on a Bruker WH500 or a Varian UnityPlus
spectrometer. Gas chromatographic (GC) analyses were carried out
on a Fisons Instruments 8000 series instrument equipped with a £ame
ionisation detector, using a DB-1 fused silica column (30 mU0.25 mm
i.d.). HPLC experiments were performed on a Gilson Gradient system
using analytical (5 mm i.d.U250 mm) or semi-prep (10 mm i.d.U250
mm) C18 reverse phase columns and monitoring the eluents at 254
nm.
2.2. DNA manipulation and recombinant protein preparation
General DNA manipulation including site-directed mutagenesis
[14], were carried out employing standard methods [15]. All possible
mutations at the 96 position were generated using a degenerate oligo-
nucleotide, and individual mutants were identi¢ed by DNA sequenc-
ing. Expression and puri¢cation of P450cam [16] and the associated
electron transfer proteins putidaredoxin and putidaredoxin reductase
[17,18] were carried out following literature methods. For wild-type
P450cam, only samples with purity ratio A392/A280 = 1.60 were used [8].
The P450cam mutants did not show complete conversion of the heme
to the high-spin state even in the presence of a large excess (1 mM) of
camphor, and their purities were assessed by the ratio of the absor-
bances at 404 nm ^ the isosbestic point for the low-spin (417 nm)/
high-spin (392 nm) conversion ^ and 280 nm. The minimum A404/A280
ratio acceptable was 1.20, which corresponds to A393/A280 = 1.60 for
the wild-type enzyme.
2.3. NADH turnover rate measurements
Incubation mixtures (1.5 ml) in a cuvette contained 50 mM Tris-
HCl bu¡er, pH 7.4, 1 WM P450cam, 5 WM putidaredoxin, 1 WM puti-
daredoxin reductase and 200 mM KCl. Substrates were added as
stocks in ethanol to a nominal ¢nal concentration of 100 WM. After
equilibrating at 30‡C for 2 min NADH was added to 200 WM and the
absorbance at 340 nm was monitored. The NADH turnover rates
were calculated using O340 nm = 6.22 mM/cm.
2.4. Naphthalene oxidation
The 1-naphthol and 2-naphthol products were clearly resolved on
the DB-1 GC column held at 120‡C (retention times 1-naphthol: 24.4
min; 2-naphthol: 25.2 min). The GC detector response of the two
naphthols at all column temperatures was identical, within experimen-
tal error.
Quantitative GC analysis was carried out at 200‡C, because 1-naph-
thol and 2-naphthol have the same retention time on the DB-1 GC
column at this temperature, which removed any uncertainties in inte-
grating the small 2-naphthol peak. A standard solution of 1-naphthol
was added to solutions (1.5 ml) containing all the components for an
NADH turnover rate incubation except NADH and naphthalene, to
give di¡erent ¢nal 1-naphthol concentrations. Each mixture was then
extracted with 750 Wl of chloroform at 4‡C by thorough vortexing
followed by centrifugation at 4000Ug, 4‡C, for 20 min. An internal
standard of para-hydroxydiphenylmethane was added to the extracts
to a ¢nal concentration of 50 WM, and 1 Wl of each sample was then
analysed by GC at 200‡C. A calibration curve of the peak area ratio
of 1-naphthol to the internal standard vs. 1-naphthol concentration
passed through the origin and was linear for the entire concentration
range. The naphthalene turnover mixtures were then extracted and
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analysed in an identical manner and the total naphthol product con-
centrations determined from the calibration curve.
2.5. Pyrene oxidation
The pyrene oxidation incubations were carried out on a 4-ml scale
to increase the product concentrations for HPLC analysis. The reac-
tion mixtures were extracted with 4 ml of CHCl3 and, after centrifu-
gation at 4000Ug, 4‡C, for 20 min to separate the layers, 3 ml of the
organic layer was removed. The CHCl3 extract was evaporated under
a stream of nitrogen and the residue redissolved in 1 ml of 40% (v/v)
acetonitrile in water. A 400-Wl aliquot was injected onto an analytical
scale C18 reverse phase HPLC column, and a gradient of 40^50% (v/
v) acetonitrile in water was developed over 30 min at a £ow rate of
1 ml/min. The retention times of the major products were 13.5 min for
1,6-pyrenequinone and 14.3 min for 1,8-pyrenequinone.
To determine the relative activities of the P450cam enzymes towards
pyrene oxidation, it was assumed that the extinction coe⁄cients at 254
nm of the two pyrenequinones were identical. The ratio of the total
product peak areas for di¡erent enzymes, standardized to an identical
amount of NADH consumed in the reactions, gave the relative cou-
pling e⁄ciency of the P450cam enzymes. The relative PAH oxidation
activities were then calculated by scaling to the reaction times.
For preparative scale incubations undertaken for product identi¢-
cation, the reaction volumes were increased to 50 ml and the incuba-
tions were carried out with stirring in 250-ml round bottomed £asks.
The substrate and products were separated on a semi-prep C18 re-
verse phase HPLC column. The mobile phase was an acetonitrile/
water mixture with a gradient of 40^50% acetonitrile being developed
over 30 min at a £ow rate of 3 ml/min.
3. Results
3.1. NADH turnover activities of the P450cam enzymes
The NADH consumption activities of the reconstituted
P450cam system with camphor, naphthalene and pyrene as
substrates are given in Tables 1 and 2. Wild-type P450cam
had the lowest activity with both naphthalene and pyrene,
and for all the P450cam enzymes studied the activity decreased
with increasing size of the PAH. The NADH turnover rates of
the Y96A and Y96F mutants with naphthalene as substrate
were particularly high, and for the Y96F mutant it was faster
than with camphor. However, since the monooxygenase activ-
ity of P450 enzymes is well known to undergo uncoupling side
reactions [19,20], not all of the NADH consumed by the sys-
tem was necessarily utilised for substrate oxidation [21]. It was
therefore important to analyse the NADH turnover reactions
for the presence of substrate oxidation products, and deter-
mine the quantities of products formed so that both the rate
of product formation and consequently the coupling e⁄ciency
could be calculated.
3.2. The oxidation of naphthalene
Wild-type P450cam and all the Y96 mutants catalysed the
oxidation of naphthalene to give a mixture of 1-naphthol and
2-naphthol, as con¢rmed by co-elution with authentic samples
by GC. There was no evidence of further oxidation of the
naphthols to catechols or other compounds. Analysis of au-
thentic samples with identical concentrations of 1- and 2-
naphthol showed that the two compounds gave the same
GC detector response. Peak area integrations showed that
all the P450cam enzymes investigated gave the same product
ratio of 97 þ 0.4% 1-naphthol to 3 þ 0.3% 2-naphthol.
The concentration response of the GC £ame-ionisation de-
tector was calibrated with 1-naphthol to determine the
amount of product formed and hence the rates of naphthalene
oxidation by the P450cam enzymes. From these rates, the im-
portant parameter of coupling e⁄ciency, i.e. the proportion of
NADH molecules consumed which lead to substrate conver-
sion, can be calculated. The naphthalene oxidation rates and
the derived coupling e⁄ciencies are listed in Table 1. All the
Y96 mutants showed higher naphthalene oxidation rates than
wild-type P450cam. The Y96F mutant was the most active,
with a naphthalene oxidation rate of 99.7 nmol Y96F/min
and coupling e⁄ciency of 55%. Although all the Y96 mutants
showed much higher coupling e⁄ciencies than wild-type
P450cam, there was no direct correlation with the NADH turn-
over rates. For instance the Y96A mutant showed much faster
NADH turnover than the Y96G, but the two mutants have
the same coupling e⁄ciency of 17%. The coupling e⁄ciency of
3% for wild-type P450cam was particularly low, and thus the
combined e¡ects of the much higher NADH turnover rates
and coupling e⁄ciencies increased the naphthalene oxidation
rates of the Y96A and Y96F mutants to 30 and 142 times,
respectively, of that of the wild-type enzyme. Indeed naphtha-
lene was a comparable substrate to camphor in the case of the
Y96F mutant.
3.3. The oxidation of pyrene
Pyrene oxidation by the P450cam enzymes gave one minor
(6 5% by HPLC) and two major products; the two major
products were puri¢ed by HPLC from a preparative scale
incubation with the Y96A mutant. The 1H NMR spectrum
of both products showed resonances in the low-¢eld region
only. Comparison with literature 1H NMR data showed that
the two products were 1,6-pyrenequinone and 1,8-pyrenequi-
none [22].
Since the pyrenequinone products were not readily avail-
able, the relative rates of formation of the pyrenequinones
and relative coupling e⁄ciencies for wild-type P450cam and
the Y96A and Y96F mutants were determined by HPLC,
and the results are shown in Table 2. As observed with naph-
thalene, the greatly increased pyrene oxidation activity of the
Y96A and Y96F mutants compared to wild-type P450cam
arose primarily from the much higher (60- and 81-fold, re-
spectively) coupling e⁄ciencies of the mutants. From an esti-
mate of the total amount of products isolated from the prep-
arative scale incubation with the Y96A mutant, the total rate
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Table 1
The rates and couplings of naphthalene oxidation catalysed by wild-type P450cam and the Y96 mutants
Naphthalene oxidation Y96G Y96A Y96V Y96F WT
NADH turnover rate 47.3 þ 3.3 119 þ 9.7 51.8 þ 4.2 181 þ 9.8 23.9 þ 4.4
Coupling e⁄ciency (%) 16.9 þ 0.9 17.0 þ 1.4 10.0 þ 0.7 55.0 þ 3.4 2.9 þ 0.2
Naphthalene oxidation rate 8.0 þ 0.3 20.2 þ 1.3 5.2 þ 0.5 99.7 þ 8.5 0.7 þ 0.2
Camphor oxidation rate 73.2 þ 4.5 155 þ 6.3 72.5 þ 5.8 160 þ 10.7 303 þ 20.5
All rates given as nmol P450cam/min and all data as mean þ S.D. from 5 independent experiments. The camphor oxidation rates of the enzymes are
included for comparison.
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of formation of the pyrenequinones was calculated to be 0.5
nmol Y96A/min. The relative proportions of the two pyrene-
quinones formed by the di¡erent enzymes are given in Table
2. The data show that the P450cam enzymes had little selectiv-
ity between the two quinones.
The observation of 1,6- and 1,8-pyrenequinone from the
oxidation of pyrene immediately suggested the involvement
of the corresponding 1,6- and 1,8-dihydroxypyrenes as inter-
mediates. These diols may in turn be formed by further oxi-
dation of 1-hydroxypyrene arising from the initial attack on
pyrene by the P450cam enzymes. The proposed 1,6- and 1,8-
dihydroxypyrene intermediates are known to be susceptible to
air oxidation to the quinones [22]. A 1-hydroxypyrene stand-
ard was well-resolved from the pyrenequinones on the HPLC
column, but 1-hydroxypyrene was not detected even in the
HPLC analysis of preparative scale incubations where the
absorbance of the pyrenequinone peaks at 254 nm far ex-
ceeded 2 O.D. units. However, 1-hydroxypyrene was oxidized
by all the P450cam enzymes, and 1,6- and 1,8-pyrenequinone
were identi¢ed as the turnover products by HPLC. The fact
that no 1-hydroxypyrene was observed could arise from either
a very low steady-state concentration or very tight binding by
the enzymes so that it did not dissociate from the enzyme
active sites before being further oxidised.
4. Discussion
We have shown that P450cam can be re-engineered by mu-
tation at a single active site residue to oxidise the polycyclic
aromatic hydrocarbons naphthalene and pyrene. The present
study, together with our earlier work [23], indicates that it is
possible to engineer P450cam to oxidise unnatural substrates
structurally unrelated to camphor, and that the Y96 residue
plays a very important role in determining the substrate range
of P450cam.
The rates of naphthalene and pyrene oxidation by the Y96
mutants were one to two orders of magnitude faster than
wild-type P450cam. The striking observation was that naphtha-
lene was a comparable substrate to camphor for the Y96F
mutant (Table 1). The rate of oxidation of the more sterically
demanding pyrene molecule was much slower (Table 2); the
estimated activity of the Y96A mutant was only 0.5 nmol
protein/min or 40-fold slower than the activity of this mutant
towards naphthalene oxidation. Nevertheless, the pyrene oxi-
dation activities of the P450cam mutants are comparable to the
PAH oxidation activity of some rat [24] and human [25] P450
enzymes.
The data indicate that the coupling e⁄ciency is an impor-
tant factor in the enhancement of the rate of PAH oxidation
by the Y96 mutants over wild-type P450cam. This was espe-
cially evident for pyrene oxidation where the NADH turnover
rates of the Y96A and Y96F mutants were only ca. 3 times
that of the wild-type, but the 60-fold (Y96A) and 81-fold
(Y96F) increases in coupling e⁄ciency gave rise to the very
large rate enhancements observed. The low coupling of 3%
determined for the oxidation of naphthalene by wild-type
P450cam is comparable to those observed for the oxidation
of other unnatural substrates such as styrene and ethylben-
zene (both ca. 5% [26,27]), and hexane (2% [11]). All the Y96
mutants showed substantially higher coupling for naphthalene
oxidation than the wild-type, with the Y96F mutant being
particularly e¡ective (55%). These increased coupling e⁄cien-
cies, together with the more modest increases in the NADH
turnover rates, gave rise to the large overall enhancement of
naphthalene oxidation activity.
The partition of uncoupling pathways in PAH oxidation
catalysed by the P450cam enzymes between peroxide genera-
tion and oxidase activity was not determined. However, in
most cases where the uncoupling has been determined, e.g.
for the oxidation of styrene, ethylbenzene, and hexane by
wild-type P450cam, the dominant mechanism was the peroxide
pathway [11,26,27]. Therefore, it is likely that the important
factor here is the reduction of peroxide formation by the Y96
mutants. The increased hydrophobicity of the mutant active
sites would disfavor water entry during the catalytic cycle,
thus reducing uncoupling by the peroxide pathway [10]. How-
ever, active site hydrophobicity is not the only factor because
the couplings varied between mutants but there was no ob-
vious correlation with the side-chain volume at the 96 posi-
tion.
The oxidation of PAHs by mammalian P450 enzymes has
been investigated in detail because of the carcinogenicity of
these compounds. Mammalian P450 enzymes oxidise PAHs to
the arene oxides which rearrange by the NIH shift mechanism
[28,29] to give isomeric phenols, although in some cases dihy-
drodiols are also formed [30]. In the presence of epoxide hy-
drolase, e.g. in oxidations by liver microsome or in vivo re-
actions, the epoxide is ring-opened to form the trans-
dihydrodiols. In the presence of an inhibitor for epoxide hy-
drolase or for in vitro reactions, naphthalene oxidation gives
predominantly 1-naphthol (s 90%) with varying amounts of
2-naphthol. We found that all the P450cam enzymes studied
here oxidised naphthalene to give the same ratio of 1-naph-
thol (97%) to 2-naphthol (3%). This is completely consistent
with the NIH shift rearrangement of a common naphthalene-
1,2-oxide intermediate. Since the 1,2-oxide is the only initial
product because the 2,3-oxide is too unstable, the results do
not give any indication of the mode of naphthalene binding
by mammalian P450s or the P450cam enzymes.
The oxidation of pyrene by mammalian P450 enzymes is
complex and the products formed vary signi¢cantly between
enzymes [31,32]. There are two sites of initial attack ^ the
non-K-region 1,2-positions and the K-region 4,5-positions
[24]. Further attacks on the initial products are also observed,
in particular 1-hydroxypyrene is susceptible to further oxida-
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Table 2
The product distribution, relative rates and couplings of the oxida-
tion of pyrene by wild-type P450cam and the Y96 mutants
All data given as mean þ S.D. from 6 independent experiments.
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tion at C6 and C8 [33]. In the oxidation of pyrene by di¡erent
P450 enzymes induced in the rat liver by injections with var-
ious xenobiotics, the major product is either the trans-4,5-di-
hydrodiol or 1-hydroxypyrene, but the 1,6- and 1,8-diqui-
nones can constitute up to 30% of the products [22,24,34].
Unlike their mammalian counterparts, the P450cam enzymes
did not attack pyrene at the K-region 4,5-positions, nor was 1-
hydroxypyrene observed in the products ^ the major products
by far (s 95% of total products) were the 1,6- and 1,8-pyr-
enequinones. This activity of the P450cam enzymes in fact
resembles fungal metabolism of pyrene where attack at the
K-region positions is not observed [35]. The major products
observed in pyrene oxidation by the P450 enzyme from the
fungus Cunninghaemella elegans arise from attack at the 1,6-
and 1,8-positions, but in this case 1-hydroxypyrene is also
observed as the minor product [22].
Since P450cam appears to follow the same mechanism of
PAH oxidation as the mammalian enzymes, it can be assumed
that the di¡erences in selectivity of pyrene oxidation are due
to the di¡erent modes of substrate binding. With the detailed
knowledge of P450cam structure and mechanism built up over
the last 30 yr, it can be envisaged that the P450cam active site
could be engineered to achieve similar selectivities of PAH
oxidation as the mammalian enzymes, especially the predom-
inant attack at the K-region positions of pyrene. The ease of
crystallization of P450cam may then allow the PAH binding
orientation to be structurally characterized and compared
with the proposed modes of PAH binding by mammalian
enzymes such as CYP1A1 [31,32].
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